The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Securities Code: 300888
Securities Abbreviation: Wanjian Medical
Announcement No.: 2026-031
300888SZSE
Progress Announcement on the Company's Share Buyback
✨ AI Summary
The company has approved a share buyback plan to reduce registered capital, with a buyback price not exceeding RMB 48 per share and a total fund of RMB 200 million to RMB 400 million. As of May 31, 2026, the company has repurchased 1,019,000 shares, representing 0.1750% of total equity, at a price range of RMB 28.53 to RMB 30.06 per share. The funding source for the buyback has been adjusted to include self-raised funds.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.